Impact of diabetes duration on achieved reductions in glycated haemoglobin, fasting plasma glucose and body weight with liraglutide treatment for up to 28 weeks: a meta‐analysis of seven phase III trials

This meta‐analysis of seven randomized, placebo‐controlled studies (total 3222 patients) evaluated whether type 2 diabetes (T2D) duration affects the changes in blood glucose control and body weight that can be achieved with liraglutide and placebo. With liraglutide 1.2 mg, shorter diabetes duration...

Descripción completa

Detalles Bibliográficos
Autores principales: Seufert, J., Bailey, T., Barkholt Christensen, S., Nauck, M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324626/
https://www.ncbi.nlm.nih.gov/pubmed/26679282
http://dx.doi.org/10.1111/dom.12623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324626/
https://www.ncbi.nlm.nih.gov/pubmed/26679282
http://dx.doi.org/10.1111/dom.12623

Ejemplares similares